MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 13, 2005; DOI: 10.1124/mol.105.015388


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.015388v1
68/4/1097    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heissig, H.
Right arrow Articles by Panten, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heissig, H.
Right arrow Articles by Panten, U.


Received for publication June 1, 2005.
Revised July 8, 2005.
Accepted for publication July 12, 2005.

Mechanism of the insulin-releasing action of {alpha}-ketoisocaproate and related {alpha}-keto acid anions

Henrike Heissig 1, Karin A. Urban 1, Katja Hastedt 1, Bernd J. Zunkler 2, Uwe Panten 3*

1 Institute of Pharmacology and Toxicology, Technical University of Braunschweig, Germany 2 Federal Institute for Drugs and Medical Devices, Bonn, Germany 3 Technical University of Braunschweig

* Address correspondence to: E-mail: u.panten{at}tu-bs.de

Abstract

{alpha}-Ketoisocaproate directly inhibits the ATP-sensitive K+ channel (KATP channel) in pancreatic {beta}-cells. But it is unknown whether direct KATP channel inhibition contributes to insulin release by {alpha}-ketoisocaproate and related {alpha}-keto acid anions which are generally believed to act via {beta}-cell metabolism. In membranes from HIT-T15 {beta}-cells and COS-1 cells expressing sulfonylurea receptor 1 (SUR1), {alpha}-keto acid anions bound to the sulfonylurea receptor site of the KATP channel with affinities increasing in the order {alpha}-ketoisovalerate < {alpha}-ketovalerate < {alpha}-ketoisocaproate < {alpha}-ketocaproate < {beta}-phenylpyruvate. Patch-clamp experiments revealed a similar order for the KATP channel-inhibitory potencies of the compounds (applied at the cytoplasmic side of inside-out patches from mouse {beta}-cells). These findings were compared with the insulin secretion stimulated in isolated mouse islets by {alpha}-keto acid anions (10 mM). When all KATP channels were closed by the sulfonylurea glipizide, {alpha}-keto acid anions amplified the insulin release in the order {beta}-phenylpyruvate < {alpha}-ketoisovalerate < {alpha}-ketovalerate {approx} {alpha}-ketocaproate < {alpha}-ketoisocaproate. The differences in amplification apparently reflected special features of the metabolism of the individual {alpha}-keto acid anions. In islets with active KATP channels, the first peak of insulin secretion triggered by {alpha}-keto acid anions was similar for {alpha}-ketoisocaproate, {alpha}-ketocaproate, and {beta}-phenylpyruvate, but lower for {alpha}-ketovalerate and insignificant for {alpha}-ketoisovalerate. This difference from the above orders indicates that direct KATP channel inhibition is not involved in the secretory responses to {alpha}-ketoisovalerate and {alpha}-ketovalerate, moderately contributes to initiation of insulin secretion by {alpha}-ketoisocaproate and {alpha}-ketocaproate, and is a major component of the insulin-releasing property of {beta}-phenylpyruvate.


Key words: Ion channel regulation, Endocrine cells


This article has been cited by other articles:


Home page
DiabetesHome page
P. Newsholme, L. Brennan, and K. Bender
Amino Acid Metabolism, {beta}-Cell Function, and Diabetes
Diabetes, December 1, 2006; 55(Supplement_2): S39 - S47.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. I. Tarasov, H. J. Welters, S. Senkel, G. U. Ryffel, A. T. Hattersley, N. G. Morgan, and F. M. Ashcroft
A Kir6.2 Mutation Causing Neonatal Diabetes Impairs Electrical Activity and Insulin Secretion From INS-1 {beta}-Cells
Diabetes, November 1, 2006; 55(11): 3075 - 3082.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics